Zobrazeno 1 - 10
of 31
pro vyhledávání: '"F W, Smart"'
Publikováno v:
Congestive heart failure (Greenwich, Conn.). 5(3)
The authors describe the surgical implantation of a left ventricular assist device (LVAD) in a patient with ischemic cardiomyopathy and recurring episodes of ventricular tachycardia with associated sudden death, as a therapeutic intervention for the
Publikováno v:
Congestive heart failure (Greenwich, Conn.). 6(6)
The use of a multisite transvenous pacemaker in a patient with refractory heart failure who experienced short-term symptomatic improvement is described. The improvement in heart failure symptoms was most likely related to resynchronization of atriove
Publikováno v:
Congestive heart failure (Greenwich, Conn.). 6(2)
The authors describe the use of spironolactone, an aldosterone receptor blocker, in a patient with heart failure refractory to conventional therapy. The clinical importance of this case is that not only does spironolactone improve symptoms, but its u
Publikováno v:
Congestive heart failure (Greenwich, Conn.). 6(3)
The authors describe the use of milrinone as a bridge to beta blockade in a patient with severe heart failure. This case is clinically important because in patients with severe heart failure phosphodiesterase inhibitors, unlike beta agonists, will re
Autor:
D O, Taylor, M L, Barr, B, Radovancevic, D G, Renlund, R M, Mentzer, F W, Smart, D E, Tolman, O H, Frazier, J B, Young, P, VanVeldhuisen
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 18(4)
Tacrolimus-based immunosuppression seems safe and effective in liver and kidney transplantation. To assess the safety and efficacy of tacrolimus (TAC)-based immunosuppression after cardiac transplantation as well as the relative impact of tacrolimus
Publikováno v:
Chest. 112(5)
This study was conducted to assess cost savings and clinical outcomes associated with the use of home i.v. inotropic therapy in patients with advanced (New York Heart Association [NYHA] class IV) heart failure.Retrospective analysis.Tertiary care ref
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 16(7)
Our current immunosuppressive strategies have made little impact on the development of cardiac allograft vasculopathy, the leading cause of long-term allograft loss. This study sought to evaluate the relationship of cellular rejection and immunosuppr
Publikováno v:
Current opinion in cardiology. 12(4)
The use of cyclosporine in solid organ transplantation has been shown to be associated with the development of hypertension and nephrotoxicity. Several mechanisms, including endothelin-mediated systemic vasoconstriction, impaired vasodilatation secon
Autor:
F W, Smart, D C, Naftel, M R, Costanzo, T B, Levine, G B, Pelletier, C W, Yancy, R E, Hobbs, J K, Kirklin, R C, Bourge
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 15(4)
By multivariable analysis, risk factors were identified for initial infection of any type, cumulative infections during the first 6 months and fatal infection among 2210 heart transplant recipients at 30 institutions.Of the 1218 infections in 695 pat
Autor:
M R, Mehra, D D, Stapleton, J L, Cook, T, Zhang, H O, Ventura, C, Huang, B, Maldonado, F W, Smart, R N, Re, J P, Murgo, R W, Barbee
Publikováno v:
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation. 15(1 Pt 1)
The long-term success of heart transplantation continues to be in jeopardy because of the development of accelerated vascular myointimal proliferation. Transfer of genes encoding products that can modulate the adverse consequences of phenomena that c